Senior Director, Value & Evidence Lead, Internal Medicine & Rare Disease Pipeline

Why Patients Need You

Our focus is on patients and understanding the critical role our medicines play to produce better health outcomes. As a cross functional team of experts, we create and execute comprehensive market access strategies through the integration of pricing and reimbursement, health technology assessment, evidence-based medicine review, and health economic modeling activities. Your expertise and innovative approach will enhance the value of our medicines and the impact to patient outcomes.

What You Will Achieve

As a leading biopharmaceutical company, Pfizer is dedicated to the discovery and delivery of high value therapies across a variety of disease areas. It is our mission to bring innovative medicines to patients that significantly improve their lives, and our priority is to ensure patients have access to these medicines.

The Value and Evidence (V&E) is responsible for ensuring patients have affordable, timely access to medicines and vaccines by advancing innovative value and evidence solutions - to inform healthcare decision-making. The V&E Asset / Indication Lead (VEAIL) will support early clinical programs and external innovative engagements to accelerate Rare Disease (RD) & Internal Medicine (IM) pipeline business.

The VEAIL will support the VET Leader to drive and maintain functional excellence, Integrated Value Evidence Strategy (IVES) and tactical execution and refinement, study planning and execution, talent attraction and development, and resource allocation for pipeline and support acceleration of external innovations.

She/he will supervise a team to ensure that V&E members contribute timely, high-quality health economics and outcomes research work to those teams. She/he will ensure appropriate methods in health economics, RWE and outcomes research, and quality of life research are applied, in accordance with PFE policies.

The VEAIL will also have individual indication support responsibilities and will partner with cross-functional teams, including Global Product Development, WRD, commercial, V&A, PCOA, medical affairs and RWE COE.

The VEAIL is responsible for fostering a OnePfizer mindset, promoting behaviors that exemplifies Pfizer's values (Courage, Excellence, Equity and Joy) within the team and prioritizing the development of team members' value and evidence competencies, and talent management.

How You Will Achieve It

• Lead and supervise teams of V&E scientists and directors for indications/assets, particularly in the tasks listed below:
• Champion payer relevant endpoints to maximize the design of Phase 3 protocols for payer needs. In particular, generating evidence within the clinical development programs and real world data studies to support the economic and humanistic aspects of our assets in development.
• Develop a COA strategy in partnership with Patient Centered Outcomes Assessment (PCOA) group
• Conduct HTA Scientific Advice when needed to for assets in the pipeline, working with Market Access, Clinical, and country colleagues
• Analyze, communicate, and publish impactful research to support the value proposition
• Ensure alignment of IVES with the overarching Integrated Value & Access strategy
• Execute the development of comprehensive global deliverables such as burden of illness studies, epidemiology studies, early health economic models, systematic literature reviews, etc. to support optimal value and access strategy
• Build, maintain strong relationships with and be the V&E champion to key stakeholders (WRDM, Medical Affairs, GPD, Regulatory, and prioritized country, health & value team) and other functions across Pfizer
• Maintain awareness of clinically relevant and scientifically valid, cutting edge HEOR studies and projects (including non-interventional studies, registries, etc.) in alignment with the global V&E strategy catered to diverse stakeholders (regulators, payers, patients, and policy makers). Explore new and innovative methodologies, and trends in the evolving healthcare landscape, to assure incorporation into the IVES within IM and RD.
• Foster a team culture that embraces collaboration, innovation, and scientific excellence with a focus on creating new capabilities to meet the needs of the evolving healthcare landscape, data generation and communication, collaboration with WRDM, GPD, Medical Affairs, to ensure successful commercialization and access, and talent development
• Manage study design of contracted research projects (budget negotiations, quality assurance of work conducted by CROs)
• Demonstrate a technical mastery in one of the following disciplines economics, epidemiology, psychometrics, and statistics.
• Drive best practice sharing across the team in support of strategy development and deepening team skills and competencies. Proactively identify and address methodological issues that may affect V&E research to support Pfizer products.
• Recruit, manage, train, and develop V&E personnel
• Participate in key cross-divisional task forces to help improve processes and standards in V&E programs
• Help define, and ensure compliance with, state of the art health economics and outcomes research processes, tools and deliverables.

Qualifications

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

Must-Have

• Bachelor's degree minimum required

• 15 years of experience minimum with a bachelor's degree; 13 years of experience minimum for a master's degree; 10 years of experience minimum for a PhD or JD in a relevant discipline such as, but not limited to, health services research, health outcomes research, epidemiology, pharmacy administration, public health, psychology, economics, statistics or decision sciences, HEOR, and / or market access & pricing fields.

• In depth strategic, methodologic, and technical understanding of pharmacoeconomic, health economic modeling, HTA, Health-Related Quality of Life, and / or market access dynamics is required

• Recent therapeutic area experience

• Experience with US and EU5 payers

• Excellent oral and written English communication skills

• Strong project management abilities (contracting, budgeting, vendor management)

• Excellent oral and written English communication skills

Nice-to-Have

• Strong technical and methodological skills (study design, data analysis, interpretation, communication) in clinical trials, epidemiology, or health services research, registries, Phase IV studies, technical peer review of HEOR research, observational study design and implementation is preferred

• Recent asset / indication-specific experience

• Knowledge and experience in early drug development and commercialization is preferred.

• Experienced in leading others (direct management or matrix leadership) with strong track record of high level of stakeholder engagement and delivering results

• Engagement experience with HTA organizations such as ICER, NICE, SMC, PBAC is preferred

• Excellent interpersonal skills are required: ability to understand and respond to multiple internal and external customers; build strategic partnerships internally and externally

Other Job Details:

• Last Date to Apply for Job: 03/31/2023
• Eligible for employee referral bonus
• Ability to travel domestically and internationally

#LI-PFE

The annual base salary for this position ranges from $199,500.00 to $332,500.00. In addition, this position offers an annual bonus with a target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program. Benefits offered include a retirement savings plan, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage in accordance with the terms and conditions of the applicable plans. Salary range does not apply to the Tampa, FL location.

Relocation assistance may be available based on business needs and/or eligibility.

Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

Market Access

#LI-PFE